Alcon Research
Clinical trials sponsored by Alcon Research, explained in plain language.
The research arm of Alcon, a global eye care company.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New study checks if popular eye drops really soothe dry eyes Results expected Sep 2026 (estimated)
- New lens tech aims to sharpen sight after cataracts Results expected Oct 2026 (estimated)
- New eye lens could let you focus without glasses after cataract surgery Results expected Oct 2026 (estimated)
- New lens implants promise clear vision at all distances after cataract surgery Results expected Oct 2026 (estimated)
- New fluid lens could sharpen vision after cataract surgery Results expected Nov 2026 (estimated)
-
New lens aims to sharpen vision after cataract surgery
Disease control Not yet recruitingThis study tests a new trifocal intraocular lens (IOL) for people having cataract surgery. The lens is designed to help see clearly at near, intermediate, and far distances. Researchers will compare the new lens to a commercially available one in 66 participants, measuring distan…
Sponsor: Alcon Research • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New eye drops promise quick redness relief in minutes
Symptom relief Not yet recruitingThis study tests an investigational eye drop (FID 123472) to see how well and how safely it reduces eye redness from minor irritations in adults. About 178 participants will receive either the active drop or a placebo (vehicle). The main goal is to measure redness reduction 15 mi…
Phase 3 • Sponsor: Alcon Research • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
New eye drops aim to soothe red eyes fast
Symptom relief Not yet recruitingThis Phase 3 trial tests an investigational eye drop (FID123472) containing apraclonidine to reduce redness in adults with minor eye irritation. About 230 participants will receive either the active drop or a placebo (vehicle). The main goals are to see if redness improves within…
Phase 3 • Sponsor: Alcon Research • Aim: Symptom relief
Last updated Aug 29, 2026 00:00 UTC
-
Can a new eye scanner match the gold standard?
Knowledge-focused Not yet recruitingThis study evaluates whether an investigational eye imaging device, UNITY DX, can measure the thickness of the cornea and its epithelial layer as accurately and consistently as a commercially available device. About 110 participants with normal or abnormal corneas will undergo mu…
Sponsor: Alcon Research • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC